Bernstein Initiates Coverage On Pfizer with Market Perform Rating, Announces Price Target of $32
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst Courtney Breen has initiated coverage on Pfizer with a Market Perform rating and set a price target of $32.
October 17, 2024 | 11:45 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bernstein has initiated coverage on Pfizer with a Market Perform rating and a price target of $32, suggesting a neutral outlook.
The Market Perform rating indicates that the analyst expects Pfizer's stock to perform in line with the market. The price target of $32 provides a specific valuation expectation, which is crucial for investors. This neutral rating suggests no significant short-term price movement is expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100